发明名称 Drug-delivery endovascular stent and method for treating restenosis
摘要 A radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, a method of using, and a method of making the stent. The stent includes a radially expandable body formed of one or more metallic filaments and a liquid-infusible mechanical anchoring layer attached to or formed in outer surface of the filaments. A drug coating in the stent is composed of a substantially polymer-free composition of an anti-restenosis drug, and has a substratum infused in the anchoring layer and a substantially continuous surface stratum of drug that is brought into direct contact with the vessel walls at the vascular site. Thus, the rate of release of the anti-restenosis drug from the surface stratum into said vascular site is determined solely by the composition of said drug coating.
申请公布号 US8871292(B2) 申请公布日期 2014.10.28
申请号 US201213556893 申请日期 2012.07.24
申请人 Biosensors International Group, Ltd. 发明人 Savage Douglas R.;Betts Ronald E.
分类号 B05D3/12;B05D3/10;A61L33/00;A61F2/06;A61L31/16;A61F2/91 主分类号 B05D3/12
代理机构 Kilpatrick Townsend & Stockton LLP 代理人 Kilpatrick Townsend & Stockton LLP
主权项 1. A method of producing a radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, comprising applying a substantially polymer-free, liquid composition of an anti-restenosis drug to a radially expandable stent body formed of one or more metallic filaments defining an outer surface, and having attached thereto, a liquid-infusible mechanical anchoring layer having an average thickness of at least 3 μm, in an amount sufficient to infuse the composition into said anchoring layer, to form a drug coating substratum within the layer, and to form over the substratum, a substantially continuous surface stratum of drug, wherein the drug coating substratum constitutes 10 to 50% of the total composition of anti-restenosis drug and wherein the rate of release of the anti-restenosis drug from the surface stratum into said site of vascular injury is determined solely by the composition of said drug coating.
地址 Hamilton BM